Chiasma, Inc. (CHMA) financial statements (2021 and earlier)

Company profile

Business Address 140 KENDRICK STREET
NEEDHAM, MA 02494
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:159213153741
Cash and cash equivalents152813153741
Other undisclosed cash, cash equivalents, and short-term investments 65    
Receivables1     
Inventory, net of allowances, customer advances and progress billings11     
Inventory11     
Other undisclosed current assets1264495458110
Total current assets:15396626995151
Noncurrent Assets
Operating lease, right-of-use asset1 
Property, plant and equipment100011
Other noncurrent assets221111
Other undisclosed noncurrent assets20     
Total noncurrent assets:2331122
TOTAL ASSETS:17699637097153
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities161110575
Accounts payable432110
Accrued liabilities1288465
Estimated litigation liability  19   
Other liabilities11 22 
Other undisclosed current liabilities     2
Total current liabilities:171129787
Noncurrent Liabilities
Long-term debt and lease obligation01    
Operating lease, liability01
Liabilities, other than long-term debt, including:4    0
Liability for uncertainty in income taxes     0
Other undisclosed liabilities, other than long-term debt4     
Other undisclosed noncurrent liabilities6311133
Total noncurrent liabilities:6821134
Total liabilities:85132971110
Stockholders' equity
Stockholders' equity attributable to parent9286346286143
Common stock100000
Additional paid in capital439358271268264260
Accumulated other comprehensive income (loss) 0(0)(0)(0)0
Accumulated deficit(348)(273)(237)(205)(179)(117)
Total stockholders' equity:9286346286143
TOTAL LIABILITIES AND EQUITY:17699637097153

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues10    
Other income 0    
Cost of revenue
(Cost of Goods and Services Sold)
(0)     
Gross profit:10    
Operating expenses(72)(38)(32)(28)(61)(35)
Other undisclosed operating loss (0)    
Operating loss:(71)(38)(32)(28)(61)(35)
Nonoperating income (expense)12111(0)
Investment income, nonoperating1     
Other nonoperating income (expense) 2111(0)
Interest and debt expense(6)(0)(0)(0)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(76)(36)(31)(28)(61)(36)
Other undisclosed income from continuing operations before income taxes100000
Loss from continuing operations before income taxes:(75)(36)(31)(27)(61)(36)
Income tax expense (benefit)(0)(0)01(0)(0)
Net loss attributable to parent:(75)(36)(31)(27)(61)(36)
Preferred stock dividends and other adjustments     (0)
Net loss available to common stockholders, diluted:(75)(36)(31)(27)(61)(36)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(75)(36)(31)(27)(61)(36)
Other comprehensive income (loss)(0)00(0)(0)0
Comprehensive loss, net of tax, attributable to parent:(75)(36)(31)(27)(61)(36)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: